Catalyst Event
Regeneron Pharmaceuticals Inc (REGN) · Earnings Release
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
4/29/2026, 12:00:00 AM
Reported Q1 2026 financial results, beating analyst expectations. Revenue increased 19% YoY to $3.6 billion, and non-GAAP EPS was $9.47. A new $3.0 billion share repurchase program was also authorized. High importance assigned due to significant earnings beat and buyback, estimated to impact price by ≥10% scheduled.
Korean Translation
2026년 1분기 재무 실적 발표, 분석가 예상 상회함. 매출은 전년 동기 대비 19% 증가한 36억 달러, 비-GAAP 주당순이익(EPS)은 9.47달러를 기록함. 또한 30억 달러 규모의 신규 자사주 매입 프로그램을 승인함. 실적 호조 및 자사주 매입으로 10% 이상의 주가 영향이 예상됨.
Related Recent Events
Bristol-Myers Squibb Co (BMY) · Other
The U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of August 17, 2026, for its decision on iberdomide for relapsed or refractory multiple myeloma, scheduled. Low impact estimated as the target date is a procedural milestone.
8/17/2026, 12:00:00 AM
Blackstone Inc (BX) · Earnings Release
Blackstone is scheduled to release its Q2 2026 earnings results, with analysts forecasting earnings of approximately $1.34-$1.36 per share, scheduled.
7/23/2026, 12:00:00 AM
Union Pacific Corp (UNP) · Earnings Release
Q2 2026 earnings release is scheduled. Low impact estimated as the date announcement is a routine event; scheduled.
7/23/2026, 12:00:00 AM
Goldman Sachs Group Inc (The) (GS) · Earnings Release
Goldman Sachs' Q2 2026 earnings release is scheduled.
7/14/2026, 12:00:00 AM
NIKE Inc (NKE) · Earnings Release
Q4 Fiscal Year 2026 earnings release is scheduled for June 25, 2026. Low importance as the announcement of the date typically has a minimal market impact.
6/25/2026, 12:00:00 AM
Vistra Corp (VST) · Other
Quarterly dividend of $0.2290 per share with an ex-dividend date of June 22, 2026; low importance estimated as dividends usually cause minor price adjustments, scheduled.
6/22/2026, 12:00:00 AM